Publications

Breast cancer research : BCR

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.

27-10-2011

Nature communications

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity.

25-10-2011

Translational oncology

Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.

01-08-2011

Annals of oncology : official journal of the European Society for Medical Oncology

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.

01-07-2011

Disease models & mechanisms

Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.

01-05-2011

Annals of oncology : official journal of the European Society for Medical Oncology

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

01-04-2011

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.

20-02-2011

Genes, chromosomes & cancer

Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.

01-02-2011

British journal of cancer

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature.

07-12-2010

Breast cancer research and treatment

A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results.

01-12-2010

Annals of surgical oncology

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.

01-09-2010

Annals of surgical oncology

Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.

01-05-2010

Annals of surgery

MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.

01-04-2010

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

01-04-2010

Annals of oncology : official journal of the European Society for Medical Oncology

A simple system for grading the response of breast cancer to neoadjuvant chemotherapy.

01-03-2010

Annals of surgery

Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.

01-03-2010

Breast cancer research and treatment

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.

01-02-2010

Annals of oncology : official journal of the European Society for Medical Oncology

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

01-01-2010

Breast cancer research and treatment

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.

01-01-2010

Breast cancer research and treatment

Validation of 70-gene prognosis signature in node-negative breast cancer.

01-10-2009

European journal of cancer (Oxford, England : 1990)

Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.

01-09-2009

Breast cancer research and treatment

The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.

01-07-2009

American journal of surgery

Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy.

01-07-2009

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Extensive soft tissue resection with autologous tissue closure for locally recurrent breast cancer: lasting local control and acceptable morbidity.

01-05-2009

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.

01-04-2009

Nederlands tijdschrift voor geneeskunde

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

15-11-2008

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

20-09-2008

The Lancet. Oncology

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

01-12-2007

Molecular biology of the cell

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

01-04-1996

British journal of cancer

Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.

01-02-1996

Biochemical Society transactions

Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas.

01-11-1995

The Journal of cell biology

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

01-04-1995

Cancer letters

Is episialin/MUC1 involved in breast cancer progression?

23-03-1995

The Journal of cell biology

The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.

01-12-1994